menopause-hrt-faq
HRT may help reduce mood swings and anxiety during perimenopause. Learn what clinical guidelines say and when to speak with a prescriber.

Not medical advice. Speak with a healthcare professional before using any medication.

For many women during perimenopause, HRT can meaningfully improve mood swings, irritability, and anxiety. According to current NAMS guidelines, hormone therapy is recognized as an effective option for mood-related symptoms when those symptoms are driven by hormonal fluctuation rather than a primary psychiatric disorder. It is not a universal solution, and individual response varies.
Here is how and why it may help:
During perimenopause, estrogen levels rise and fall unpredictably. Per published clinical guidelines, estrogen plays a role in regulating neurotransmitters involved in emotional stability, including serotonin, dopamine, and GABA. When estrogen fluctuates, these pathways become less steady, which can contribute to:
According to the Endocrine Society, stabilizing estrogen levels through hormone therapy may support these brain pathways and reduce emotional volatility in women whose symptoms are hormonally driven.
If a prescriber determines that a compounded preparation is medically appropriate, it is important to note: Compounded medications are not FDA-approved. They have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved medications should be considered first when commercially available options meet patient needs.
According to ACOG, mood improvement in these groups may become apparent within weeks of achieving stable hormone levels, though individual timelines vary.
If anxiety or depression existed long before hormonal changes, HRT may still provide some benefit, but per published clinical guidelines, it generally works best alongside other evidence-based treatments such as therapy, lifestyle interventions, or medication when indicated. HRT is not a replacement for standard mental health treatment when symptoms are unrelated to hormonal fluctuation.
According to current NAMS guidelines, HRT is among the most studied options for mood and anxiety symptoms that begin or worsen during perimenopause or menopause. When the underlying cause is hormonal instability, stabilizing hormone levels may support emotional steadiness, improved sleep, and reduced anxiety. Per the Endocrine Society, most women can expect to assess whether they are experiencing benefit within one to three months of consistent therapy.
Whether HRT is appropriate depends on individual health factors. A prescriber should determine the best approach based on a patient's complete medical history.
Have questions about compounding? Contact Voshell's Pharmacy — we prepare patient-specific medications pursuant to valid prescriptions from your licensed prescriber.